Efficacy and safety of di- rect oral anticoagulants during pregnancy; a systematic literature review. Thromb Res. 2018;169:123 7. 31. Beyer-Westendorf J, Michalski F, Tittl L, et al. Pregnancy outcome in pa- tients exposed to direct oral anticoagulants - and the challenge of event reporting. Thromb Haemost. 2016;116:651 8. 32. Cohen H, Arachchillage DR, Middeldorp S, et al. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14:1673 6. 33. Quinn J, Von Klemperer K, Brooks R, et al. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience. Haematologica. 2009;94:1608 12. 34. James AH, Brancazio LR, Gehrig TR, et al. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. J Matern Fetal Neonatal Med. 2006;19:543 9. 35. Meschengieser SS, Fondevila CG, Santarelli MT, et al. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart. 1999;82:23 6. 36. De Santo LS, Romano G, Della Corte A, et al. Mitral mechanical replace- ment in young rheumatic women: analysis of long-term survival, valve- related complications, and pregnancy outcomes over a 3707-patient-year follow-up. J Thorac Cardiovasc Surg. 2005;130:13 9. 37. Al-Lawati AA, Venkitraman M, Al-Delaime T, et al. Pregnancy and me- chanical heart valves replacement; dilemma of anticoagulation. Eur J Car- diothorac Surg. 2002;22:223 7. 38. De Santo LS, Romano G, Della Corte A, et al. Mechanical aortic valve replace- ment in young women planning on pregnancy: maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehen- sive pre-operative counseling protocol. J Am Coll Cardiol. 2012;59:1110 5. 39. McLintock C, McCowan LM, North RA. Maternal complications and preg- nancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG. 2009;116:1585 92. 40. 